Peter Kiener
Director/Board Member bij LAVA THERAPEUTICS N.V.
Vermogen: 675 $ op 31-03-2024
Oorsprong van het eerstegraads netwerk van Peter Kiener
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 220 | |
University of Massachusetts
187
| College/University | Other Consumer Services | 187 |
Intermediate Capital Group Plc (Private Equity)
 Intermediate Capital Group Plc (Private Equity) Investment ManagersFinance Intermediate Capital Group Plc (Private Equity) (ICG) is a private equity division of Intermediate Capital Group Plc founded in 1989. The firm is headquartered in London, United Kingdom.
112
| Operating Division | Investment Managers | 112 |
| Public Company | Pharmaceuticals: Major | 74 | |
University of Oxford
66
| College/University | Other Consumer Services | 66 |
| Subsidiary | Pharmaceuticals: Major | 27 | |
| Public Company | Biotechnology | 25 | |
| Public Company | Biotechnology | 21 | |
| Public Company | Biotechnology | 20 | |
University of North Texas
19
| College/University | Other Consumer Services | 19 |
University of Lancaster
15
| College/University | Other Consumer Services | 15 |
AbCellera Boston, Inc.
 AbCellera Boston, Inc. BiotechnologyHealth Technology AbCellera Boston, Inc. produces vaccines for plant, animal, and human diseases. It focuses on the discovery of novel therapeutics for autoimmune disease and pain. The company was founded by Theodore G. Clark in 2004 and is headquartered in Arlington, MA.
14
| Subsidiary | Biotechnology | 14 |
Wugen, Inc.
 Wugen, Inc. Packaged SoftwareTechnology Services Wugen, Inc. develops CAR-T therapy platform for cancer therapies. The company was founded by Matthew Cooper and John F. DiPersio and is headquartered in St. Louis, MO.
11
| Holding Company | Packaged Software | 11 |
| Public Company | Pharmaceuticals: Major | 8 | |
Resolve Therapeutics LLC
 Resolve Therapeutics LLC BiotechnologyHealth Technology Resolve Therapeutics LLC operates as a biotechnology company. It engages in the development of biotechnology drugs. The firm specializes in treatment of debilitating autoimmune diseases such as Systemic Lupus Erythematous and Sjogren’s syndrome. The company was founded by James Posada in 2010 and is headquartered in Seattle, WA.
6
| Holding Company | Biotechnology | 6 |
Bridge Valley Ventures LLP
 Bridge Valley Ventures LLP Investment ManagersFinance Bridge Valley Ventures LLP is a Venture Capital firm founded in 2017. Bridge Valley Ventures LLP is headquartered in Cambridge.
5
| Private Company | Investment Managers | 5 |
| Subsidiary | Pharmaceuticals: Major | 5 | |
Zyngenia, Inc.
 Zyngenia, Inc. Drugstore ChainsRetail Trade Zyngenia, Inc. developed new class of bio-therapeutics. The company was founded by Joseph L. Amprey III, Carlos F. Barbas III and Peter Alec Kiener in 2008 and headquartered in Gaithersburg, MD.
3
| Private Company | Drugstore Chains | 3 |
Itolerance, Inc.
 Itolerance, Inc. BiotechnologyHealth Technology Itolerance, Inc. is an American biotechnology company that specializes in developing regenerative medicines. The private company was founded by Cameron Gray and is currently led by CEO Anthony J. Japour.
2
| Private Company | Biotechnology | 2 |
Cereius, Inc.
 Cereius, Inc. BiotechnologyHealth Technology Cereius, Inc. develops novel radio-labeled therapeutics for treating solid tumor brain metastasis. The firm delivers new targeted classes of both radiologic diagnostics and radiotherapeutics for the treatment of cancers in the brain. The company was founded by Kimberly Blackwell and Michael R. Zalutsky in 2017 and is headquartered in Durham, NC.
1
| Subsidiary | Biotechnology | 1 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Peter Kiener via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal General Counsel | |
| E I DU PONT DE NEMOURS AND CO | Chemicals: Agricultural | Director/Board Member Chief Tech/Sci/R&D Officer | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Sales & Marketing | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| Washington University in St. Louis | College/University | Corporate Officer/Principal Doctorate Degree | |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Corporate Officer/Principal Human Resources Officer | |
| BIOGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| TRANSGENE | Biotechnology | Director/Board Member Director/Board Member | |
JPMorgan Securities LLC
 JPMorgan Securities LLC Investment Banks/BrokersFinance JPMorgan Securities LLC (JPMS) is a securities brokerage firm headquartered in New York City. The firm was founded in 1985 and is a subsidiary of JPMorgan Broker-Dealer Holdings, Inc., ultimately held by JPMorgan Chase & Co., Inc. (NYSE: JPM). JPMS provides research on fixed income, credit, derivatives, emerging markets, foreign exchange, structured finance, technical analysis and bond indices. Their equity analysts cover equities throughout North America, EMEA, Asia/Pacific and the emerging markets. The firm's fixed income team formulates trading and portfolio recommendations for investors in global bonds and other fixed-income markets based on valuations, analytics and market dynamics. | Investment Banks/Brokers | Corporate Officer/Principal Analyst-Equity | |
| SANOFI | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Chief Operating Officer | |
| MEAD JOHNSON NUTRITION CO | Food: Meat/Fish/Dairy | Director/Board Member Director/Board Member | |
| The Trustees of Columbia University in The City of New York | College/University | Corporate Officer/Principal Undergraduate Degree | |
| Stanford University | College/University | Masters Business Admin Doctorate Degree Graduate Degree | |
| University of Pennsylvania | College/University | Graduate Degree Graduate Degree | |
| INTERMEDIATE CAPITAL GROUP PLC | Financial Conglomerates | Director/Board Member Director/Board Member Chief Executive Officer Corporate Officer/Principal | |
| Boston University | College/University | Masters Business Admin Corporate Officer/Principal Undergraduate Degree | |
| University of Cambridge | College/University | Undergraduate Degree Undergraduate Degree | |
| University of California, Los Angeles | College/University | Undergraduate Degree Undergraduate Degree | |
| Massachusetts Institute of Technology | College/University | Graduate Degree Undergraduate Degree Doctorate Degree | |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Undergraduate Degree Corporate Officer/Principal Undergraduate Degree | |
| Tufts University | College/University | Undergraduate Degree Chairman Corporate Officer/Principal | |
| University of California, Irvine | College/University | Undergraduate Degree Undergraduate Degree | |
| University of Georgia | College/University | Corporate Officer/Principal Doctorate Degree | |
| University of Illinois | College/University | Undergraduate Degree Doctorate Degree | |
| University of Michigan | College/University | Undergraduate Degree Undergraduate Degree | |
| University of Durham | College/University | Undergraduate Degree Undergraduate Degree | |
| PDL BIOPHARMA, INC. | Biotechnology | Director of Finance/CFO Director/Board Member | |
| London Business School | College/University | Masters Business Admin Masters Business Admin | |
Pharmaceutical Research & Manufacturers of America
 Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member Director/Board Member Chairman | |
The Bioindustry Association
 The Bioindustry Association Miscellaneous Commercial ServicesCommercial Services The BioIndustry Association is a UK-based organization that represents the life sciences and biotech industry. The British company's mission is to facilitate and connect the ecosystem to help businesses start, grow, and deliver world-changing innovation. The non-profit company was founded by Cormac G. Kilty and Simon Geoffrey Best, and Steve Bates has been the CEO of the company since 2012. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| Albert Einstein College of Medicine, Inc. | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
Convergence Pharmaceuticals Ltd.
 Convergence Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Convergence Pharmaceuticals Ltd. develops novel analgesics for the treatment of chronic pain. It provides CNV1014802, a small molecule state-dependent sodium channel blocker; and CNV1061436, a sodium channel blocker for the treatment of central nervous system disorders, including epilepsy and bipolar disorder. The company was founded by Brenda Reynolds in September 2010 and is headquartered in Cambridge, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member Founder | |
Exicure Operating Co.
 Exicure Operating Co. Pharmaceuticals: MajorHealth Technology Exicure Operating Co. operates as a biopharmaceutical company commercializing spherical nucleic acid constructs as gene regulation and modulation agents for diseases including applications in oncology, dermatology, neurology, and for immune disorders. The SNA constructs allow the use of oligonucleotide-based therapies to treat diseases in a range of tissue types. The company was founded by Chad A. Mirkin and Colby Shad Thaxton in 2011 and is headquartered in Skokie, IL. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| George Washington University Law School | College/University | Graduate Degree Graduate Degree Graduate Degree | |
| The University of Chicago Booth School of Business | College/University | Masters Business Admin Masters Business Admin | |
| Washington University School of Medicine | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
Pieris Pharmaceuticals GmbH
 Pieris Pharmaceuticals GmbH BiotechnologyHealth Technology Part of Pieris Pharmaceuticals, Inc., Pieris Pharmaceuticals GmbH operates as a German biotechnology company. The private company is based in Hallbergmoos, Germany. The CEOs of the company are Hitto Kaufmann, Stephen S. Yoder. | Biotechnology | Chief Executive Officer Chief Executive Officer | |
| IMMUNITYBIO, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Tiger Midco Ltd.
 Tiger Midco Ltd. Financial ConglomeratesFinance Founded in 2016, Tiger Midco Ltd. is a British company that functions as an investment holding company. Part of Intermediate Capital Group Plc, the private company is based in Bexhill-on-Sea, UK. | Financial Conglomerates | Director/Board Member Director/Board Member | |
| EXICURE, INC. | Biotechnology | Chairman Director/Board Member | |
| AURINIA PHARMACEUTICALS INC. | Biotechnology | Director/Board Member Chief Executive Officer |
Statistieken
Internationaal
| Verenigde Staten | 36 |
| Verenigd Koninkrijk | 9 |
| Frankrijk | 3 |
| Duitsland | 3 |
| Israël | 2 |
Sectoraal
| Health Technology | 22 |
| Consumer Services | 20 |
| Finance | 6 |
| Process Industries | 3 |
| Consumer Non-Durables | 2 |
Operationeel
| Director/Board Member | 414 |
| Corporate Officer/Principal | 223 |
| Independent Dir/Board Member | 121 |
| Chief Executive Officer | 76 |
| Chairman | 74 |
Sterkste connecties
| Insiders | |
|---|---|
| Timothy Walbert | 40 |
| Peter Greenleaf | 31 |
| David Parkinson | 31 |
| Karen Wilson | 31 |
| Paul Edick | 27 |
| James Geraghty | 25 |
| John McKearn | 25 |
| Maureen O'Connell | 24 |
| Jean Bizzari | 24 |
| Bosun Hau | 23 |
| Lamberto Andreotti | 23 |
| Alison Taunton-Rigby | 23 |
| Frank Morich | 21 |
| Benoît Durteste | 21 |
| Fred Driscoll | 21 |
- Beurs
- Insiders
- Peter Kiener
- Bedrijfsconnecties
